CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy
============================================================================================================================================================================================================

* Anne Y Lai
* Jessica A Sorrentino
* Konstantin H Dragnev
* Jared M Weiss
* Taofeek K Owonikoko
* Julie A Rytlewski
* Jill Hood
* Zhao Yang
* Rajesh K Malik
* Jay C Strum
* Patrick J Roberts